Moderna Aktie

Moderna für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2N9D9 / ISIN: US60770K1079

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
01.06.2020 12:05:11

Stock Alert: Moderna Shares Up 4% In Premarket

(RTTNews) - Shares of Moderna Inc. (MRNA) are currently trading at $64.00, up $2.50 or 4.07% in the pre-market session. The stock has been trading in the range of $11.54 - $87.00 for the past one year, and closed Friday's trade at $61.50, up $5.96 or 10.73%.

The company, on May 29, announced that the first participants in each age cohort have been dosed in Phase 2 study of its mRNA vaccine candidate (mRNA-1273) against the novel coronavirus or SARS-CoV-2.

This Phase 2 study, being conducted by Moderna under its own Investigational New Drug application, would evaluate the safety, reactogenicity and immunogenicity of two vaccinations of mRNA-1273 given 28 days apart. The company intends to enroll 600 healthy participants across two cohorts of adults ages 18-55 years and older adults ages 55 years and above.

Further, the company expects to initiate Phase 3 trial in July, subject to finalization of the clinical trial protocol.

Analysen zu Moderna Incmehr Analysen

19.11.24 Moderna Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
13.09.24 Moderna Underweight JP Morgan Chase & Co.
05.08.24 Moderna Sector Perform RBC Capital Markets
12.01.24 Moderna Outperform RBC Capital Markets
03.11.23 Moderna Buy Goldman Sachs Group Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Moderna Inc 23,50 0,84% Moderna Inc